Group 1 - The "siphon effect" in first-tier cities remains strong, with Beijing leading in job application activity, followed by new first-tier cities like Chengdu and Chongqing showing high recruitment activity [1] - The most in-demand positions include service staff, sales specialists, clerks, beauticians, chefs, and general workers, indicating a growing employment potential in the service and manufacturing sectors due to rising service consumption and traditional industry transformation [1] - The rapid development of the platform economy is breaking traditional employment boundaries, providing job seekers with more flexible and diverse options, which is a significant driver of talent mobility across cities and industries [1] Group 2 - The delivery industry is focusing on the Yangtze River Delta cities, with job applications in Suzhou, Hangzhou, Shanghai, and Chongqing seeing a rise of over 5% [2] - The growth in the e-commerce sector and increased subsidies from delivery platforms have stimulated diverse consumer demands for instant delivery, leading to a continuous increase in related job requirements [2] - The average job application rate for driver positions in the top 15 cities increased by 8.1%, with cities like Hangzhou, Shanghai, Suzhou, Xi'an, and Chongqing experiencing over 10% growth, highlighting the appeal of flexible job opportunities in the ride-hailing sector [2]

如今，情绪价值主导的全新叙事，让IP超越时间、年龄的限制成为可能。IP产业正在升级之中，产品设计从功能满足转向情感共振，叙事载体突破单一媒 介束缚，本土IP加速全球化渗透。在当下文娱产业的全球化浪潮中，IP正在成为文化输出的通用语言。 "从农场到工厂，从工厂到乐园，从中国到全球。"这几乎是侯晓楠IP全产业链运营及全球运营的三部曲。侯晓楠一直相信，IP是撬动消费的超级变量。在 他看来，消费即表达，IP即身份，情感消费将驱动千亿生态圈。打通内容-体验-商业的链路，IP将成为深入年轻圈层的通行证。 侯晓楠是阅文IP宇宙的"织网者"。仅2024这一年的时间里，阅文就新增了约33万名作家、65万本小说，以及420亿中文字符。此外，全网霸屏TOP30的剧 集中，每两部就有一部是来自阅文出品或阅文IP。今年年初，侯晓楠提出"在海外再造一个阅文"，这更标志着新赛点的临近。 侯晓楠于2020年4月加入阅文，担任阅文集团总裁，随后于2023年5月出任阅文集团首席执行官兼总裁。五年来，这位北航计算机系出身、兼具产品经理敏 锐与创业者魄力的CEO，将阅文锻造成"IP宇宙的织网者"，以"IP农场-IP工厂-IP乐园"三阶战略，让中国故 ...

Core Viewpoint - The Hong Kong stock market has shown resilience and vitality, with the Hang Seng Index and Hang Seng Tech Index rising by 20% and 18.68% respectively in the first half of 2025, driven by significant inflows of southbound funds [1][2] Group 1: Market Performance - The Hong Kong stock market has outperformed globally, entering a technical bull market, primarily due to the revaluation of Chinese assets and the alignment with the rapid development of AI and consumption upgrades [1][3] - Southbound funds have significantly contributed to the market's strength, with net purchases exceeding 730 billion HKD in the first half of the year, nearly double the amount from the same period last year [1][2] Group 2: Characteristics of Southbound Funds - The inflow of southbound funds has been characterized by explosive growth and structural optimization, with institutional funds accounting for about 70% of the total inflow [2][3] - In the first quarter alone, southbound funds reached a record high of 440 billion HKD, indicating strong institutional interest, particularly from public funds and insurance companies [2][3] Group 3: Investment Opportunities - Four categories of scarce assets in the Hong Kong market are highlighted: AI applications, innovative pharmaceuticals, new consumption, and dividend-paying stocks [3][4] - AI-related assets represent over 60% of the market capitalization in the tech sector, making them a focal point for investment as the sector experiences significant growth [4][5] - New consumption assets also account for approximately 60% of the market capitalization in the consumption sector, reflecting changing consumer preferences [4][5] Group 4: Changing Investment Logic - The investment logic for innovative pharmaceuticals has shifted from being concept-driven to being fundamentally driven, supported by policy enhancements and improved R&D capabilities [5][6] - New consumption trends are evolving from short-term themes to long-term structural opportunities, with a focus on products that resonate with younger consumers [6][7] Group 5: Outlook for the Second Half - The Hong Kong stock market is expected to continue its bull market in the second half of the year, supported by ample liquidity and favorable industry cycles [7] - Key investment areas include scarce assets that are unique to the Hong Kong market and closely aligned with current industry trends, particularly in AI applications and dividend stocks [7]

| 港股通(沪)活跃成交股 | | --- | | 小米集团-W HK 01810 | 5.72亿 | 6.04亿 | 11.76亿 -3151.82万 | | --- | --- | --- | --- | | 中国平安 | 8.47亿 | 3.23亿 | 11.70亿 | | HK 02318 | | | +5.24亿 | | 香港交易所 | 6.17亿 | 3.62亿 | 9.78亿 | | HK 00388 圖片立語· 知道 叶 久 | | | +2.55 乙 | 港股通(深)活跃成交股 7月11日港股市场，北水成交净买入17.44亿港元，其中港股通(沪)成交净卖出21.97亿港元，港股通(深) 成交净买入39.41亿港元。 北水净买入最多的个股是美团-W(03690)、中国平安(02318)、港交所(00388)。北水净卖出最多的个股是 小米集团-W(01810)、阿里巴巴-W(09988)、腾讯(00700)。 | 股票名称 | 买入额 | 卖出额 | 买卖总额 | | --- | --- | --- | --- | | | | | 净流入 | | 中州证券 HK 01375 | 44.02亿 | ...

证券代码：300921 证券简称：南凌科技 南凌科技股份有限公司 投资者关系活动记录表 服务。而南凌科技提供的服务与基础运营商业务有着显著区别， 首先公司是第三方中立的网络服务商，可结合多家运营商基础网 络资源提供服务；其次公司具备自主研发的软硬件产品与技术， 为客户网络与安全的持续运作提供服务。目前，公司服务的客户 还是以外资企业、中外合资企业、民营企业等为主。同时，公司 提供的是多元化云网安融合服务，在自研 SD-WAN 产品的基础 上研发 SASE 产品，通过自主研发与产业深度融合，将网络与安 全结合在一起，并以云服务形式进行交付，满足数字企业的动态 安全访问需求，形成公司进一步的竞争优势。 1 编号：2025-007 投资者关系 活动类别 √特定对象调研□分析师会议 □ 媒体采访□业绩说明会 □ 新闻发布会□ 路演活动 □ 现场参加□其他 参与单位名称 国金证券、德邦证券资管、拓森资本 时间 2025 年 7 月 8 日 10:00-11:30 地点 公司总部会议室 上市公司接待 人员 董事会秘书喻荔女士 投资者关系 活动主要内容 公司董事会秘书喻荔女士简要对公司2024年及2025年一季 度经营状况 ...

据"美团Meituan"公众号7月10日消息，当地时间7月8日，国务院总理李强在里约热内卢出席在巴西中资 企业座谈会。美团出海业务Keeta负责人仇广宇作为互联网企业代表参加座谈会。 仇广宇表示，Keeta将致力于打造可持续发展业务，为消费者带来更丰富的消费选择，并助力本地创造 更多就业机会。美团及Keeta在提升商户与骑手数字技能方面的经验，将有效用于改善经营状况与个人 生计。无论是美团还是Keeta，我们都坚信，在消费者获得更优体验的同时，平台上的每一位参与者都 应当实现共同成长。 金砖国家工商论坛是金砖国家领导人会晤的重要配套活动，其宗旨是促进金砖国家工商界对话磋商、深 化经贸合作、表达新兴国家工商界声音。今年论坛共有金砖国家1000余名工商界代表参与。 李强总理在座谈会上表示，这些年，中国企业"走出去"步伐加快、国际化经营能力增强，对国内经济建 设的重要性也在日益上升。 2025年5月12日，巴西总统卢拉与美团CEO王兴会面，并见证巴西出口投资促进局（ApexBrasil）与 Keeta签署投资协议。美团将在今年正式将旗下外卖服务Keeta引入巴西，并计划5年内在巴西投入10亿 美元支持该项目的发展。 ...

2025 年 7 月 11 日 分析师：陈伟光 S0340520060001 电话：0769-22119430 邮箱： chenweiguang@dgzq.com.cn 周 分析师：罗炜斌 S0340521020001 电话：0769-22110619 邮箱：luoweibin@dgzq.com.cn 资料来源：东莞证券研究所，iFind 相关报告 通信行业 超配（维持） 通信行业双周报（2025/6/27-2025/7/10） 行 业 AI 带来 DWDM 流量增长 投资要点： 本报告的风险等级为中高风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者谨慎判断，据此入市，风险自担。 请务必阅读末页声明。 SAC 执业证书编号： S0340524070002 电话：0769-22119302 邮箱： chenzhanqian@dgzq.com.cn SAC 执业证书编号： 通信行业指数近两周涨跌幅：申万通信板块近2周（6/27-7/10）累计上 涨3.91%，跑赢沪深300指数2.29个百分点，涨幅在31个申万一级行业中 位列第9位；申万通信板块7月累计上涨0.19%，跑输沪深300指数 ...

本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 股东名称 | 视京呈通信（上海）有限公司 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 控股股东、实控人及一致行动人 | | | | □是 | | √否 | | | | 直接持股 5%以上股东 | | | □是 | √否 | | | | | | 股东身份 | | | | | | | | | | 董事、监事和高级管理人员 | | | | □是 | √否 | | | | | 其他：5%以下股东 | | | | | | | | | | 32,802,770股 持股数量 | | | | | | | | | | 持股比例 0.66% | | | | | | | | | | 当前持股股份来源 | 其他方式取得：32,802,770股 | | | | | | | | | 上述减持主体无一致行动人。 | | | | | | | | | | 二、减持计划的实施结果 | ...

Group 1 - The company expects a net profit attributable to shareholders for the first half of 2025 to be between -10 million and -5 million yuan, indicating a loss compared to the same period last year [1][2] - The estimated net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -23.15 million and -18.15 million yuan [2] - The preliminary financial data is subject to final confirmation in the official 2025 semi-annual report [1][2] Group 2 - The previous year's profit total was 19.93 million yuan, with a net profit attributable to shareholders of 0.01 yuan per share [2] - The main reasons for the expected loss include an investment loss of approximately -13.52 million yuan and a decline in consolidated operating revenue due to subsidiaries exiting or transforming their business [2]

7月10日，慢性肾脏病新药开同®复方α-酮酸片300片在京东健康线上首发。该药为肾脏营养原研药物， 由费森尤斯卡比公司研发。京东健康将充分发挥自身全渠道优势和医疗健康服务能力，提升这款新药的 可及性，帮助慢性肾脏病患者获得更便捷、更经济的长期治疗方案，降低断药和停药风险，提升患者长 期用药依从性。 开同®复方α-酮酸片的生产企业费森尤斯卡比是德国费森尤斯集团旗下的核心业务公司，长期专注于为 重症及慢性病患者提供高质量的医疗解决方案。深耕中国市场四十余年，费森尤斯卡比在药品、临床营 养、医疗器械等领域均积累了深厚的专业实力。 京东健康联合包括费森尤斯卡比在内的药企合作伙伴，致力于为患者提供优质的药品供给。此外，京东 健康率先在行业内打通"医+检+诊+药"全链路闭环，能为各类慢性病患者提供更便捷、更科学、更专业 的一站式诊疗方案。 未来，京东健康将继续深化药企合作，在进一步提升慢性病所需药品可及性的同时，持续优化患者的长 期用药体验，推动我国慢性病防治水平的提升。 慢性肾脏病是威胁人类健康的主要疾病之一。根据《柳叶刀》最新研究数据，目前我国成人慢性肾脏病 患者达1.323亿，患病率达10.8%，即每10个人中就有 ...